|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02186 LUYE PHARMA
Nominal 
1.810 -0.055 (-2.949%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 3,002,079 | -5.628% | 3,181,110 | 3,074,582 | 2,904,108 | 2,850,826 |
| Cost of Sales | (1,099,821) | 7.457% | (1,023,501) | (996,032) | (960,745) | (800,742) |
| Gross Profit | 1,902,258 | -11.835% | 2,157,609 | 2,078,550 | 1,943,363 | 2,050,084 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (16,153) | 34.362% | (12,022) | 345 | 232 | 568 | |
| Profit / (Loss) before Taxation | 515,410 | 12.623% | 457,640 | 529,977 | 228,988 | 375,373 | |
| Taxation | (134,611) | 34.266% | (100,257) | (91,799) | (83,634) | (72,187) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 9,695 | -- | (44,497) | (50,342) | 4,623 | (6,189) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 390,494 | 24.804% | 312,886 | 387,836 | 149,977 | 296,997 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 304,280 | -10.099% | 338,460 | 234,134 | 255,565 | 168,666 |
| Depreciation & Amortisation | 431,536 | 5.733% | 408,138 | 348,305 | 331,431 | 326,472 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 9.780 | 17.548% | 8.320 | 10.310 | 4.060 | 8.540 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 3.836 | -- | 3.906 | 3.461 | 3.013 | 2.403 |
| Remarks: | Real time quote last updated: 10/09/2026 11:11 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 390,494 |
| %Change | 24.804% |
| EPS / (LPS) | RMB 0.098 |
| NBV Per Share (¥) | RMB 3.836 |